February 25, 2021
73
1
1.37%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
23:55Now PlayingA bipartisan pair of lawmakers is pursuing a first-in-the-nation approach to reduce the cost of some prescription drugs. Senator Carla Nelson, R-Rochester, and Representative Jennifer Schultz, DFL-Duluth, held a press conference Wednesday, February 24, to introduce a bill that will expand access to less expensive biosimilar products by requiring health plans and pharmacy benefit managers to offer coverage.
Rep. Schultz said that biologic prescription drugs “have a monopoly essentially.” According to Senator Nelson, “Biologics are the significant driver of prescription drug spending in the U.S., accounting for about forty percent of total prescription drug spending.” Nelson said she wants to ensure Minnesotans have access to the less expensive biosimilar products.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.